86 research outputs found

    Boswellia: Systematically scoping the in vitro, in vivo and clinical research

    Get PDF
    Introduction Boswellia is a genus of shrubs or small/medium trees in which there is continued interest in a number of species for their potential medicinal use. . This review aimed to produce a ‘map’ of research on Boswellia to identify the potential for translation of research findings across different areas and identify any research gaps. Methods Searches were carried out using major databases for in vitro, in vivo and clinical studies on any condition or disease, involving Boswellia species and extracts. Data were extracted on the health condition or disease, study type, Boswellia species and form being investigated. Results 5296 records were retrieved resulting in 657 relevant research papers; 297 (45.2%) reported in vitro studies, 236 (40.0%) reported in vivo studies, and 68 (10.3%) reported clinical studies. Studies were located corresponding to 20 of 21 health research categories, the most frequently researched being Cancer and Neoplasms, Inflammatory and Immune System, and Infection. The species Boswellia serrata and Boswellia sacra have undergone most investigation. Different forms of Boswellia were employed with boswellic acids, specifically Acetyl-11-keto-β-Boswellic acid (AKBA) and 11-Keto-β-Boswellic acid (KBA) generating most interest. Significant numbers of animal studies were located but few clinical studies. Conclusions The extent, range and nature of the research on extracts and products derived from Boswellia species is revealed. Research is highlighted which may have more widely applicable results (for example on pharmacokinetics, delivery and toxicity), as are current research gaps and potential targets for greater collation of existing data to reduce duplication

    Nurse-led cognitive behavioural therapy for respiratory patients

    Get PDF
    Anxiety and depression are common comorbidities of chronic obstructive pulmonary disease and have a negative impact on patients’ physical functioning, use of healthcare resources and mortality. Risk factors for and rates of psychological difficulties are currently higher due to the coronavirus pandemic. A recent trial demonstrated the clinical effectiveness of a cognitive behavioural therapy intervention delivered by respiratory nurses, and surveys have shown they feel psychological support is an important part of their role. Barriers remain to patients receiving mental health support; however, this intervention could provide an important step towards improving access

    Searching for real-world effectiveness versus efficacy of healthcare innovations: the case of social prescribing for diabetes

    Get PDF
    Background: Social prescribing is a process whereby primary care patients are linked or referred to nonmedical sources of support in the community and voluntary sector. It is a concept that has arisen in practice and implemented widely in the United Kingdom and has been evaluated by various organizations. Objective: The aim of our study was to characterize, collate, and analyze the evidence from evaluation of social prescribing for type 2 diabetes in the United Kingdom and Ireland, comparing information available on publicly available websites with the published literature. Methods: We used a broad, pragmatic definition of social prescribing and conducted Web-based searches for websites of organizations providing potentially relevant services. We also explored linked information. In parallel, we searched Medline, PubMed, Cochrane Library, Google Scholar, and reference lists for relevant studies published in peer-reviewed journals. We extracted the data systematically on the characteristics, any reported evaluation, outcomes measured and results, and terminology used to describe each service. Results: We identified 40 UK- or Ireland-based projects that referred people with type 2 diabetes and prediabetes to nonmedical interventions or services provided in the community. We located evaluations of 24 projects; 11 as published papers, 12 as Web-based reports, and 1 as both a paper and a Web-based report. The interventions and services identified included structured group educational programs, exercise referral schemes, and individualized advice and support with signposting of health-related activities in the community. Although specific interventions such as community-based group educational programs and exercise referral have been evaluated in randomized controlled trials, evaluation of individualized social prescribing services involving people with type 2 diabetes has, in most cases, used pre-post and mixed methods approaches. These evaluations report generic improvement in a broad range of outcomes and provide an insight into the criteria for the success of social prescribing services. Conclusions: Our study revealed the varied models of social prescribing and nonmedical, community-based services available to people with type 2 diabetes and the extent of evaluation of these, which would not have been achieved by searching databases alone. The findings of this scoping study do not prove that social prescribing is an effective measure for people with type 2 diabetes in the United Kingdom, but can be used to inform future evaluation and contribute to the development of the evidence base for social prescribing. Accessing Web-based information provides a potential method for investigating how specific innovative health concepts, such as social prescribing, have been translated, implemented, and evaluated in practice. Several challenges were encountered including defining the concept, focusing on process plus intervention, and searching diverse, evolving Web-based sources. Further exploration of this approach will inform future research on the application of innovative health care concepts into practice

    Towards More Predictive, Physiological and Animal-free In Vitro Models: Advances in Cell and Tissue Culture 2020 Conference Proceedings

    Get PDF
    Experimental systems that faithfully replicate human physiology at cellular, tissue and organ level are crucial to the development of efficacious and safe therapies with high success rates and low cost. The development of such systems is challenging and requires skills, expertise and inputs from a diverse range of experts, such as biologists, physicists, engineers, clinicians and regulatory bodies. Kirkstall Limited, a biotechnology company based in York, UK, organised the annual conference, Advances in Cell and Tissue Culture (ACTC), which brought together people having a variety of expertise and interests, to present and discuss the latest developments in the field of cell and tissue culture and in vitro modelling. The conference has also been influential in engaging animal welfare organisations in the promotion of research, collaborative projects and funding opportunities. This report describes the proceedings of the latest ACTC conference, which was held virtually on 30th September and 1st October 2020, and included sessions on in vitro models in the following areas: advanced skin and respiratory models, neurological disease, cancer research, advanced models including 3-D, fluid flow and co-cultures, diabetes and other age-related disorders, and animal-free research. The roundtable session on the second day was very interactive and drew huge interest, with intriguing discussion taking place among all participants on the theme of replacement of animal models of disease
    • …
    corecore